BofA raised the firm’s price target on Pactiv Evergreen to $12 from $11 and keeps a Neutral rating on the shares in consideration of recent gains in the shares as well as the firm’s review of comparable and market multiples.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PTVE: